CIDARA THERAPEUTICS
Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics. The company focuses on developing innovative therapies to treat life-threatening illnesses exacerbated by deficiencies of the human immune system. Cidara Therapeutics was founded in 2012 and headquartered in San Diego, California.
CIDARA THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2012-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.cidara.com
Total Employee:
51+
Status:
Active
Contact:
858-230-8519
Email Addresses:
[email protected]
Total Funding:
156.06 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
858 Therapeutics
858 Therapeutics is a stealth company specializing in the area of healthcare services, pharmaceutical, and biotechnology.
Adaptive Symbiotic Technologies
Adaptive Symbiotic Technologies is a biotechnology company that specializes in the fields of agriculture and farming.
Asher Bio
Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.
Biofourmis
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics.
Capricor Therapeutics
Capricor Therapeutics is a biotechnology company focusing on cell and exosome-based therapeutics.
Cayman Chemical
Cayman Chemical is a biotechnology firm that provides assay kits, antibodies, proteins, biochemicals, and contract services.
CB Therapeutics
CB Therapeutics is a biotech company that specializes in the biosynthetic production of cannabinoids from sugar.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Children's Therapeutic Strategies
Children's Therapeutic Strategies is a company specialized in individual, family therapy infant mental health and trauma therapy services.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
EnginZyme
EnginZyme is a biotechnology company that specializes in biocatalysis.
Flexion Therapeutics
Flexion Therapeutics is a biotechnology company that develops long-lasting intra-articular injection therapies to treat osteoarthritis.
GeneThera
GeneThera is a biotechnology company, dedicated to improving food safety by applying the latest molecular technologies
Iksuda Therapeutics
Iksuda Therapeutics is a biotechnology company specializing in the development of next generation biotherapeutics
Gross-Wen Technologies
Gross-Wen Technologies is a biotechnology company that specializes in the fields of water quality, wastewater, and water nitrogen.
HelioBioSys
HelioBioSys is a biotechnology company that specializes in marine cyanobacteria.
Heron Therapeutics
Heron Therapeutics is a biotechnology firm specializing in polymer-based pharmaceuticals.
Implanet
Implanet is a biotechnology company that provides implants for healthcare professionals treating orthopaedic patients.
Intelligent Sensory concept
Biolux Medical is biotechnology company that specializes in photomodulation.
Joylux
Joylux is a health and wellness company that specializes in women's health and wellness.
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Pasithea Therapeutics
Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health.
Plakous Therapeutics
Plakous Therapeutics is a human biologics company that specializes in restorative and regenerative healing.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Seer
Seer is a medical technology company that specializes in addressing neurological conditions.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
UVLrx Therapeutics
UVLrx Therapeutics is a biotechnology company that specializes in the fields of medical, healthcare, and therapeutics.
Verenium
Verenium is an industrial biotechnology company specializing in the development of high performance enzymes.
Vystar
Vystar is a publicly-traded biotechnology company that is engaged in the rubber and plastic products market.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Cidara Therapeutics
CARB-X
CARB-X investment in Grant - Cidara Therapeutics
Square 1 Bank
Square 1 Bank investment in Post-IPO Debt - Cidara Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Cidara Therapeutics
Sabby Capital
Sabby Capital investment in Series B - Cidara Therapeutics
venBio Partners
venBio Partners investment in Series B - Cidara Therapeutics
5AM Ventures
5AM Ventures investment in Series B - Cidara Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Series B - Cidara Therapeutics
Aisling Capital
Aisling Capital investment in Series B - Cidara Therapeutics
Fidelity
Fidelity investment in Series B - Cidara Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-01 | Cidara Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Financial Officer and Chief Business Officer, and Shane Ward as Chief Legal Officer and Corporate Secretary |
Official Site Inspections
http://www.cidara.com Semrush global rank: 509.98 K Semrush visits lastest month: 96.68 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cidara Therapeutics"
Cidara Therapeutics - Crunchbase Company Profile
Cidara Therapeutics is a biotechnology company that specializes in the fields … See details»
Cidara Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
6 days ago SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to … See details»
Cidara Therapeutics - The Org
Cidara is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases that are inadequately … See details»
Cidara Therapeutics, Inc. - Devex
Learn more about Cidara Therapeutics, Inc.'s jobs, projects, latest news, contact information and geographical presence. Cidara is developing long-acting therapeutics designed to improve the ... See details»
Revolutionizing Treatment: Cidara Therapeutics Secures $105M in …
Nov 29, 2024 Cidara Therapeutics is excited to announce the successful completion of a $105 million funding round, a significant milestone that will propel its innovative initiatives in the field … See details»
Targeted Immunotherapy for Transformative Outcomes - Cidara …
Contact Us. Cidara Therapeutics, Inc. 6310 Nancy Ridge Drive, Suite 101 San Diego, CA 92121. p: (858) 752-6170 e: [email protected] See details»
Cidara Therapeutics | The Pharmaletter
Cidara Therapeutics Cidara is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel anti-infectives. The firm is applying its proprietary … See details»
Cidara Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug … See details»
Cidara Therapeutics Provides Corporate Update and Reports
Nov 8, 2024 Cidara Therapeutics is using its proprietary Cloudbreak ® platform to develop novel drug-Fc conjugates (DFCs) comprising targeted small molecules or peptides coupled to a … See details»
Cidara Therapeutics announces board changes, CMO separation
Jan 8, 2025 SAN DIEGO – Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biopharmaceutical company with a market capitalization of $296 million and trading near its 52-week high of … See details»
Cidara Therapeutics to Participate in World Health - GlobeNewswire
Mar 19, 2025 Cidara Therapeutics to Participate in World Health Organization Meeting on H5N1 Influenza Preparedness and Response March 19, 2025 08:00 ET | Source: Cidara … See details»
Cidara Therapeutics to Participate in World Health Organization …
SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug … See details»
Corporate Presentation - cidara.com
Cidara cautions that the foregoing list of factors is not exclusive and not to place undue reliance upon any forward-looking statements ... immunocompromised; MCO, Managed Care … See details»
Cidara Therapeutics Provides Corporate Update and Reports
May 8, 2025 Cidara Therapeutics management will host a conference call and webcast beginning at 5:00 pm ET / 2:00 pm PT today, May 8, 2025. A live webcast may be accessed … See details»
Corporate Governance - Cidara Therapeutics
As Senior Vice President of the commercial organization, Mr. Spencer led the successful commercial launch of the industry’s first and only two-dose hepatitis B vaccine – HEPLISAV … See details»
Cidara Announces Pricing of Upsized Public Offering of
1 day ago The study met its primary and all secondary efficacy endpoints for all dose groups Single doses of 450mg, 300mg and 150mg of CD388 conferred 76%, 61% and 58% … See details»
Cidara Therapeutics Presents New Promising Preclincal Data on …
Dec 7, 2023 Cidara is currently advancing its dual CD73/PD-1 inhibitor DFC and CBO421 in preclinical studies. The company plans to file an investigational new drug (IND) application in … See details»
CBO-421 - Drug Targets, Indications, Patents - Synapse - Patsnap
May 24, 2025 SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to … See details»
Cidara stock soars as antiviral drug succeeds in flu study
3 days ago Cidara will provide detailed results at a future medical meeting and intends to meet with the Food and Drug Administration to discuss the design of a Phase 3 trial. Study success … See details»
Newsroom - Cidara Therapeutics
Apr 30, 2025 RBC Global Healthcare Conference: Ahead of an important trial readout next month, Jeff Stein explains Cidara’s unique approach to influenza and how it differs from … See details»